Concepedia
Statistics
Publications
1
Citations
45
H-Index
Active since
2010
R. C. Newton is an author specializing in her2 inhibitors, matrix metalloproteinase processing, and metastatic her2-positive breast cancer.
Publications per year
2010–2010
Clinical benefit of INCB7839, a potent and selective ADAM inhibitor, in combination with trastuzumab in patients with metastatic HER2+ breast cancer.
R. C. Newton, E C Bradley, Richard S. Levy et al. · Journal of Clinical Oncology · 2010 · 45 citations
Medicine, Oncology, Pharmacology +17
1–1 of 1